Franklin, Tenn.-based Acadia Healthcare reported a fourth-quarter net loss attributable to Acadia of $13.02 per diluted share after recording a $996.2 million non-cash goodwill impairment charge, the company said in its fourth-quarter and full-year 2025 results.
Here are five things to know:
- Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024. Same facility revenue increased 4.4%, including a 3.1% increase in patient days and a 1.3% increase in revenue per patient day.
- Acute inpatient psychiatric facility revenue was $451 million in the fourth quarter and saw a 10% increase over the prior year’s fourth quarter, with inpatient volumes up 6%.
- Adjusted net income attributable to Acadia totaled $6.1 million, or $0.07 per diluted share, compared with $59.2, or $0.64 per diluted share in the prior-year period. Adjusted EBITDA was $99.8 million, compared with $153.1 million in the prior-year period, and included a $52.7 million adjustment to professional and general liability reserves.
- For full-year 2025, revenue totaled $3.3 billion, a 5% increase compared to the prior year. Net loss attributed to Acadia totaled $12.16 per diluted share, compared with net income of $2.78 per diluted share during the prior year. Adjusted EBITDA was $608.9 million, compared with $709 million in the previous year.
- The company added 181 newly licensed beds during the fourth quarter and 1,089 licensed beds during the year.
- Acadia issued full-year 2026 guidance that includes revenue of $3.37 billion to $3.45 billion and adjusted EBITDA of $575 million to $610 million.
